REPATHA sol inj 140 mg/ml stylo
7680656220019
CH-65622
C10AX13
07.12.0.
Reimbursement limitations:
REPATHA.01
REPATHA est remboursé en accompagnement d’un régime alimentaire et en complément d’une thérapie intensive à …
1 / 3
google
Details
- Product number
- 6562201
- CPT
- -
- Packaging group
- 1
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- evolocumabum 140 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Repatha 140 mg / ml, Vorgefüllter Pen
Vorgefüllter Pen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 205.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2017
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65622
- Drug name
- Repatha, Vorgefüllter Pen
- Galenic form
- LSINJ
- ATC Code
- C10AX13
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/02/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.12.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REPATHA sol inj 140 mg/ml stylo
- Description (DE)
- REPATHA Inj Lös 140 mg/ml Pen
- Market launch
- 05/02/2016
- Narcotic (BTM)
- No